IRIS Accounts Production v23.3.0.418 11905256 director 1.4.22 31.3.23 31.3.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh119052562022-03-31119052562023-03-31119052562022-04-012023-03-31119052562021-03-31119052562021-04-012022-03-31119052562022-03-3111905256ns10:Originalns15:EnglandWales2022-04-012023-03-3111905256ns14:PoundSterlingns10:Original2022-04-012023-03-3111905256ns10:Originalns10:Director12022-04-012023-03-3111905256ns10:Original2022-04-012023-03-3111905256ns10:Original2023-03-3111905256ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3111905256ns10:Originalns10:SmallEntities2022-04-012023-03-3111905256ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3111905256ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3111905256ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3111905256ns10:Originalns10:FullAccounts2022-04-012023-03-3111905256ns10:Original12022-04-012023-03-3111905256ns10:Originalns10:RegisteredOffice2022-04-012023-03-3111905256ns10:Original2022-03-3111905256ns10:Originalns5:CurrentFinancialInstruments2023-03-3111905256ns10:Originalns5:CurrentFinancialInstruments2022-03-3111905256ns10:Originalns5:Non-currentFinancialInstruments2023-03-3111905256ns10:Originalns5:Non-currentFinancialInstruments2022-03-3111905256ns5:ShareCapitalns10:Original2023-03-3111905256ns5:ShareCapitalns10:Original2022-03-3111905256ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3111905256ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3111905256ns10:Originalns5:NetGoodwill2022-04-012023-03-3111905256ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-04-012023-03-3111905256ns10:Originalns5:LandBuildings2022-04-012023-03-3111905256ns10:Originalns5:PlantMachinery2022-04-012023-03-3111905256ns10:Original2021-04-012022-03-3111905256ns10:Originalns5:NetGoodwill2022-03-3111905256ns10:Originalns5:NetGoodwill2023-03-3111905256ns10:Originalns5:NetGoodwill2022-03-3111905256ns10:Originalns5:LandBuildings2022-03-3111905256ns10:Originalns5:PlantMachinery2022-03-3111905256ns10:Original2022-03-3111905256ns10:Originalns5:LandBuildings2023-03-3111905256ns10:Originalns5:PlantMachinery2023-03-3111905256ns10:Originalns5:LandBuildings2022-03-3111905256ns10:Originalns5:PlantMachinery2022-03-3111905256ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3111905256ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3111905256ns5:Securedns10:Original2023-03-3111905256ns5:Securedns10:Original2022-03-3111905256ns10:Originalns5:DeferredTaxation2022-04-012023-03-3111905256ns10:Originalns5:DeferredTaxation2023-03-31
REGISTERED NUMBER: 11905256 (England and Wales)















A2 HEALTH LTD

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023






A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 March 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


A2 HEALTH LTD

COMPANY INFORMATION
for the year ended 31 March 2023







DIRECTOR: J T Vadodaria





REGISTERED OFFICE: Swillington Pharmacy Church Lane
Swillington
Leeds
LS26 8DY





REGISTERED NUMBER: 11905256 (England and Wales)





ACCOUNTANTS: Sheards
Chartered Accountants
Vernon House
40 New North Road
Huddersfield
West Yorkshire
HD1 5LS

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

BALANCE SHEET
31 March 2023

2023 2022
Notes £    £   
FIXED ASSETS
Intangible assets 4 1,019,403 1,019,403
Tangible assets 5 243,019 242,696
1,262,422 1,262,099

CURRENT ASSETS
Stocks 88,862 108,749
Debtors 6 158,290 129,709
Cash at bank and in hand 57,951 99,493
305,103 337,951
CREDITORS
Amounts falling due within one year 7 (249,661 ) (198,968 )
NET CURRENT ASSETS 55,442 138,983
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,317,864

1,401,082

CREDITORS
Amounts falling due after more than one
year

8

(1,130,146

)

(1,284,122

)

PROVISIONS FOR LIABILITIES 10 (3,295 ) -
NET ASSETS 184,423 116,960

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 184,323 116,860
SHAREHOLDERS' FUNDS 184,423 116,960

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

BALANCE SHEET - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 29 October 2023 and were signed by:





J T Vadodaria - Director


A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 March 2023


1. STATUTORY INFORMATION

A2 Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the sale of goods is recognised when the significant risk and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Goodwill
Goodwill is considered to have an indefinite life that can be demonstrated, and the value of the goodwill can be readily measured. The dispensing chemist industry, in which the company operates, has high market entry
barriers due to the nature of licence agreements with local health authorities and the limited number available in the marketplace. The value of the business can be ascertained by reference to the current value of goodwill which is payable in the market based on a price per £ in relation to the levels of turnover for each individual pharmacy. The director reviews the value of goodwill on an annual basis and considers it to be worth in excess of the net book value.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 2% on cost
Plant and machinery etc - 33% on cost, 25% on cost and 10% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2023


2. ACCOUNTING POLICIES - continued

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2022 - 8 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2022
and 31 March 2023 1,059,196
AMORTISATION
At 1 April 2022
and 31 March 2023 39,793
NET BOOK VALUE
At 31 March 2023 1,019,403
At 31 March 2022 1,019,403

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2023


5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 April 2022 233,335 10,541 243,876
Additions - 7,583 7,583
At 31 March 2023 233,335 18,124 251,459
DEPRECIATION
At 1 April 2022 - 1,180 1,180
Charge for year 4,667 2,593 7,260
At 31 March 2023 4,667 3,773 8,440
NET BOOK VALUE
At 31 March 2023 228,668 14,351 243,019
At 31 March 2022 233,335 9,361 242,696

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 118,084 103,251
Other debtors 40,206 26,458
158,290 129,709

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 37,369 -
Trade creditors 160,401 149,953
Taxation and social security 23,934 41,264
Other creditors 27,957 7,751
249,661 198,968

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans 1,000,496 1,080,059
Other creditors 129,650 204,063
1,130,146 1,284,122

A2 HEALTH LTD (REGISTERED NUMBER: 11905256)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2023


8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued
2023 2022
£    £   
Amounts falling due in more than five years:

Repayable by instalments
Bank loans 844,863 880,672

9. SECURED DEBTS

The following secured debts are included within creditors:

2023 2022
£    £   
Bank loans 1,037,865 1,080,059

The bank loan to acquire the business and property is secured over the property and by way of fixed and floating charge of the assets of the business, combined with an insurance policy over the life of the director.

Government backed loans are secured by way of government initiative.

10. PROVISIONS FOR LIABILITIES
2023 2022
£    £   
Deferred tax 3,295 -

Deferred
tax
£   
Charge to Income Statement during year 3,295
Balance at 31 March 2023 3,295

11. RELATED PARTY DISCLOSURES

At the year end, £131,413 (2022: £204,063) was owed to some of the shareholders directly, or through a company in which a shareholder is also a shareholder.

Interest is being paid on the loans at commercial rate of interest.

12. ULTIMATE CONTROLLING PARTY

The controlling party is Ms L Garapathi.